Coeptis Therapeutics Inc.
COEP | NASDAQ
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.07 | -0.97 | -18.89 | -10.67 | -15.20 | -452.89 |
PEG Ratio | 0.10 | 0 | 0.27 | 0.14 | -0.01 | 0 |
PS Ratio | 44.27 | n/a | n/a | n/a | 2.73K | 135.43K |
PB Ratio | 3.50 | 3.32 | 93.38 | 98.30 | 86.96 | -809.96 |
P/FCF Ratio | -7.01 | -1.59 | -55.64 | -112.94 | -32.76 | -1.33K |
P/OCF Ratio | -7.01 | -1.59 | -55.64 | -112.94 | -45.53 | -1.33K |
OCF/S Ratio | -631.16 | n/a | n/a | n/a | -5.99K | -10.2K |
Debt / Equity Ratio | 0.02 | 0.44 | 0.28 | 0.46 | 1.74 | -0.41 |
Quick Ratio | 4.16 | 0.23 | 0.59 | 1.81 | 0.79 | 0.04 |
Current Ratio | 4.16 | 0.23 | 0.59 | 1.81 | 0.79 | 0.04 |
Asset Turnover | 0.07 | n/a | n/a | n/a | 0.01 | 0.10 |
Interest Coverage | -20.30 | -25.38 | -199.57 | -156.57 | -75.06 | -46.30 |
Return on Equity | -69.09% | -335.32% | -492.97% | -843.73% | -572.16% | 178.02% |
Return on Assets | -60.06% | -119.89% | -263.49% | -474.68% | -198.79% | -3.05K% |
Return on Invested Capital | -71.70% | -178.73% | -352.58% | -447.90% | -218.36% | 224.56% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 86.75% | n/a | n/a | n/a | 100% | -3.03K% |
Net Profit Margin | -874.29% | n/a | n/a | n/a | -17.93K% | -29.77K% |
Pretax Profit Margin | -900.72% | n/a | n/a | n/a | -17.93K% | -29.77K% |
Operating Profit Margin | -956.94% | n/a | n/a | n/a | -18.73K% | -22.31K% |
FCF Margin | -631.16% | n/a | n/a | n/a | -8.32K% | -10.2K% |
EBITDA Margin | -763.89% | n/a | n/a | n/a | -17.09K% | -28.23K% |
Add to Watchlist
Select watchlists to add or remove COEP